SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ----------- (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2010 - -------------------------------------------------------------------------------- OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from __________ to __________ Commission File Number 000-9519 -------- REGENT TECHNOLOGIES, INC. - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) COLORADO 84-0807913 - -------------------------------------------------------------------------------- (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 5646 Milton, Suite 722 Dallas, Texas 75206 (Address of principal executive offices) 214-694-2227 (Issuer's telephone number) Regent Petroleum Corporation (Former name of Issuer) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (the "Exchange Act") during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No ------ ------ Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer --- --- Non-accelerated filer Smaller reporting company --- --- (Do not check if a smaller reporting company) Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes X No ------ ------ The number of outstanding shares of the issuer's only class of common stock as of August 1, 2010 was 8,706,900. REGENT TECHNOLOGIES, INC. AND SUBSIDIARY (A DEVELOPMENT STAGE COMPANY) INDEX TO FORM 10-Q June 30, 2010 Page Nos. -------- PART I. FINANCIAL INFORMATION Item 1. Financial Statements Consolidated Balance Sheets (Unaudited) 1 at June 30, 2010 and December 31, 2009 (Audited) Consolidated Statements of Operations (Unaudited) 2 For the Three and Six Months Ended June 30, 2010 and 2009 For the Period from Inception (January 1, 1999) to June 30, 2010 Consolidated Statements of Cash Flows (Unaudited) 3 For the Six Months Ended June 30, 2010 and 2009 For the Period from Inception (January 1, 1999) to June 30, 2010 Notes to Consolidated Financial Statements 4 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 7 Item 3. Quantitative and Qualitative Disclosures About Market Risk 10 Item 4. Controls and Procedures 10 PART II. OTHER INFORMATION Item 1. Legal Proceedings 10 Item 1A. Risk Factors 10 Item 2. Changes in Securities 11 Item 3. Defaults Upon Senior Securities 11 Item 4. Submission of Matters to a Vote of Security Holders 11 Item 5. Other Information 11 Item 6. Exhibits and Reports on Form 8-K 11 SIGNATURE 12 EXHIBIT INDEX 13 PART I. FINANCIAL INFORMATION Item 1. Financial Statements - ------- -------------------- REGENT TECHNOLOGIES, INC. AND SUBSIDIARY (A DEVELOPMENT STAGE COMPANY) CONSOLIDATED BALANCE SHEET June 30, December 31, 2010 2009 ------------------ ------------------ (Unaudited) Audited ASSETS CURRENT ASSETS Cash in bank $ 8,872 $ 5,297 --------- --------- Total Current Assets 8,872 5,297 Long-term note receivable, stockholder 70,000 70,000 Property and equipment: Furniture and fixtures 8,593 8,593 Computer equipment 4,186 2,400 --------- --------- 12,779 10,993 Less accumulated depreciation ( 11,082) ( 10,993) --------- --------- Net property and equipment 1,696 - Investments in affiliate (Note 5) 386,316 395,620 --------- --------- TOTAL ASSETS $ 466,885 $ 470,917 ========= ========= LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable, trade $ 642 $ 2,606 Note payable, related parties 4,350 8,850 Accrued interest payable 593 265 --------- --------- Total Current Liabilities 5,585 11,721 --------- --------- STOCKHOLDERS' EQUITY Convertible Preferred stock, $.10 par value, 1,000,000 shares authorized, 99,500 and 94,500 shares issued and outstanding, Regent GLSC Technologies, Inc. 9,950 9,450 Preferred stock, $.10 par value, 30,000,000 shares authorized, no shares issued and outstanding, Registrant - - Common stock, $.01 par value, 100,000,000 shares authorized, 8,706,900 and 8,487,456 shares issued and outstanding 87,069 84,875 Paid-in capital in excess of par 3,840,296 3,815,795 Accumulated deficit (including $128,015 deficit accumulated since reentering the development stage) (3,476,015) (3,450,924) --------- --------- 461,300 459,196 --------- --------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 466,885 $ 470,917 ========= ========= The accompanying notes are an integral part of the consolidated financial statements. 1 REGENT TECHNOLOGIES, INC. AND SUBSIDIARY (A DEVELOPMENT STAGE COMPANY) CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2010 AND 2009 AND FOR THE PERIOD JANUARY 1, 1999 THROUGH JUNE 30, 2010 (UNAUDITED) For the For the For the For the three three six six Cumulative months months months months Since Re-entering ended June ended June ended June ended June Development Stage 30, 2010 30, 2009 30, 2010 30, 2009 January 1, 1999 ------------ ------------ ------------ ------------ ------------ Revenues $ - $ - $ - $ - $ - Operating expenses: General and administrative 7,216 2,468 14,384 8,817 331,063 Depreciation expense 89 - 89 - 89 --------- --------- --------- --------- --------- Operating loss ( 7,305) ( 2,468) ( 14,473) ( 8,817) (331,152) --------- --------- --------- --------- --------- Other income and (expense): Gain on fair value measurement - - ( 9,304) - 58,236 Gain on extinguishment of debt - - - - 145,340 Gain on sale of investment - - - - 76,581 Stock grant expense ( 2,194) ( 2,250) ( 2,194) ( 2,250) ( 40,167) Interest, net 273 ( 335) 880 ( 620) ( 36,853) --------- --------- --------- --------- --------- Total other income (expense) ( 1,921) ( 2,585) ( 10,618) ( 2,870) 203,137 --------- --------- --------- --------- --------- Income (loss) from continuing operations before income taxes ( 9,226) ( 5,053) ( 25,091) ( 11,687) (128,015) Provisions for income taxes - - - - - --------- --------- --------- --------- --------- Net income (loss) ( 9,226) ( 5,053) ( 25,091) ( 11,687) (128,015) ========= ========= ========= ========= ========= Net income (loss) per common share (basic and diluted) $( .00) $( .00) $( .00) $( .00) ========= ========= ========= ========= Weighted Average Shares Outstanding 8,523,628 7,074,544 8,505,642 7,043,569 The accompanying notes are an integral part of the consolidated financial statements. 2 REGENT TECHNOLOGIES, INC. AND SUBSIDIARY (A DEVELOPMENT STAGE COMPANY) CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED JUNE 30, 2010 and 2009 AND FOR THE PERIOD JANUARY 1, 1999 THROUGH JUNE 30, 2010 (UNAUDITED) 						 		 		 Cumulative Since Re-entering For the Six Months Ended June 30, Development Stage 2010 2009 January 1, 1999 ------------ ------------ ------------ CASH FLOWS FROM OPERATING ACTIVITIES: Net income (loss) $( 25,091) $( 11,687) $(128,015) Adjustments to reconcile net income (loss) to net cash used in operating activities: Depreciation 89 - 3,851 Gain (loss) from fair value measurement - - (103,201) Change in fair value measurement 9,304 - 44,966 Gain from extinguishment of debt - - (145,340) Gain from sale of investment - - ( 76,581) Note issued for settlement expenses - - 20,000 Common stock issued for services 2,194 2,250 45,166 Common stock issued in legal settlement - - 14,000 Decrease in settlements and note receivable - - 4,800 Decrease in other assets - - 1,967 Increase in allowance for uncollectible settlements - - 79,892 Increase (decrease) in accounts payable, trade ( 1,963) 5,390 31,974 Increase (decrease) in accrued interest payable 328 620 25,329 --------- --------- --------- Net Cash Used In Operating Activities ( 15,139) ( 3,427) (181,192) --------- --------- --------- CASH FLOWS FROM INVESTING ACTIVITIES: Investment in affiliates - - (350,000) Capital expenditures for equipment (1,786) - ( 1,786) Proceeds from sale of investments - - 100,000 --------- --------- --------- Net Cash Used In Investing Activities ( 1,786) - (251,786) --------- --------- --------- CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from note payable - related party - - 110,055 Proceeds from sale of Preferred Stock 25,000 - 427,500 Proceeds from note payable - stockholder - 2,580 20,000 Repayments of notes payable ( 4,500) - (115,705) --------- --------- --------- Net Cash Provided By Financing Activities 20,500 2,580 441,850 --------- --------- --------- Net Increase (Decrease) in Cash 3,575 ( 847) 8,872 Cash At Beginning Of Period 5,297 886 - --------- --------- --------- Cash At End of Period $ 8,872 $ 39 $ 8,872 ========= ========= ========= SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES -------------------------------------------------------------------- Issuance of common stock upon conversion of notes payable $ - $ - $ 193,840 Common stock issued for director stock awards $ 2,194 $ 2,250 $ 45,166 Common stock issued for bonus compensation $ - - $ 20,000 Common stock returned in failed consideration and debt settlement $ - $ - $ 510,960 Note receivable as partial consideration for purchase of preferred stock $ - $ - $ 70,000 Repayment of note payable transferred directly to MacuCLEAR upon sale to GHI, Ltd. $ - $ - $(150,000) Partial sale of MacuCLEAR holdings to GHI, Ltd. $ - $ - $ 148,500 Issuance of common stock upon MacuCLEAR sale to GHI, Ltd. $ - $ - $ 1,500 The accompanying notes are an integral part of the consolidated financial statements. 3 REGENT TECHNOLOGIES, INC. AND SUBSIDIARY (A DEVELOPMENT STAGE COMPANY) NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS Note 1. BASIS OF PRESENTATION The accompanying unaudited consolidated financial statements included herein have been prepared by REGENT TECHNOLOGIES, INC. (the "Registrant" or "Company") pursuant to the rules and regulations of the Securities and Exchange Commission for interim financial information, and do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments, which are of a normal recurring nature, necessary to reflect a fair presentation of the results for the interim periods presented. The results of operations for such interim periods are not necessarily indicative of what may occur in future periods. In preparing the accompanying unaudited consolidated financial statements, the Company has reviewed, as determined necessary by the Company's management, events that have occurred after June 30, 2010, up until the issuance of the financial statements, which occurred on August 16, 2010. Note 2. SIGNIFICANT ACCOUNTING POLICIES The significant accounting policies of the Company are described in Note 1 to the 2009 consolidated financial statements of the 2009 Form 10-K, and the criti- cal accounting policies and estimates are described in Management's Discussion and Analysis included in Item 7 of the 2009 Form 10-K and in Item 2 of this quarterly report. In management's opinion, the accounting policies and estimates presented in the 2009 Form 10-K have not changed and therefore the unaudited consolidated financial statements herein should be read in conjunction with the Company's audited report on Form 10-K for the period ended December 31, 2009, that was previously filed with the Securities and Exchange Commission. Note 3. GOING CONCERN UNCERTAINTIES As of the date of this quarterly report, there is substantial doubt regarding our ability to continue as a going concern as we have not generated sufficient cash flow to fund our business operations and material commitments. Our future success and viability, therefore, are dependent upon our ability to generate capital financing. We are optimistic that we will be successful in our new business operations and capital raising efforts; however, there can be no assurance that we will be successful in generating revenue or raising additional capital. The failure to generate sufficient revenues or raise additional capital may have a material and adverse effect upon the Company and our shareholders. These consolidated financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying consolidated financial statements. Note 4. CAPITAL STRUCTURE DISCLOSURES Common and preferred stock - -------------------------- The Company's capital structure is complex and consists of preferred stock and a general class of common stock. The Company is authorized to issue 130,000,000 shares of stock, of which 30,000,000 have been designated as preferred shares with a par value per share of $.10, and 100,000,000 have been designated as common shares with a par value per share of $.01. As of the date of this filing, there is no preferred stock outstanding and there are 8,706,900 shares of common stock are outstanding. This compares to 7,262,456 shares for the same period in 2009 with the difference due to stock issuances under stock-based compensation (see notes to the consolidated financial statements of the 2009 Form 10-K). 4 Stock options - ------------- In 1998, in connection with a private placement of the Company's common shares, the Company issued 333,333 warrants to purchase restricted common stock at $1.00 per share and expiring on June 30, 2003. In 1999, the Company issued to a director an option to purchase 100,000 shares of the Company's common stock at an exercise price of $.25 and expiring on June 30, 2004. Other than the above options and warrants, no other options, warrants or similar rights have been granted and all options have expired without execution. Subsidiary preferred stock - -------------------------- On April 18, 2007, Regent GLSC accepted purchase agreements in a total amount of $150,000 received from four purchasers of a private offering of shares of of Series A Convertible Preferred Stock ("Regent GLSC Preferred Stock"). Under the accepted purchase agreements, the subscribers purchased through a Preferred Stock Purchase Agreement 30,000 shares of Regent GLSC's Series A Convertible Preferred Stock at $5.00 per share. The stock was sold under a private placement offering to sell 25% of the equity of Regent GLSC for $1,250,000 in $50,000 units. Each unit is convertible into 10,000 shares of common stock of Regent GLSC plus 4,800 shares of common stock of MacuCLEAR. Including the initial sales on April 18, 2007, Regent GLSC has accepted Preferred Stock purchase agreements from additional investors for a total amount of $497,500, including a purchase and sale of 5,000 shares of Series A Preferred Stock for $5 per share with the spouse of the CEO of Regent GLSC, effective January 7, 2010. As of the date of this filing, there are 99,500 shares of Series A Preferred Stock outstanding. If all of the unconverted shares of the Series A Preferred Stock were converted to common stock of Regent GLSC, the Company's ownership of Regent GLSC would be diluted to approximately 90%. Note 5. INVESTMENTS IN AFFILIATE As of the date of this quarterly filing, Regent GLSC holds title to 126,428 shares of MacuCLEAR Preferred Stock, of which 95,858 shares are beneficially held for the holders of Regent GLSC Preferred Stock. The Company has adopted ASC 820 which defines fair value and the framework for using fair value to measure assets and liabilities, and expands disclosures about fair value measurements. Under this process, the Company has determined the fair value for the MacuCLEAR Preferred Stock has not changed from the $4.50 per share for the period ended December 31, 2009. See Note 6 in the notes to the consolidated financial statements of the 2009 Form 10-K for more information. Also, see Note 6 herein. Due to the sale in January, 2010 of 5,000 shares of Regent GLSC Preferred Stock, the number of shares beneficially owned by the Company was reduced from 35,454 to 30,570. We applied the $4.50 per share as the measurement of fair value for our holdings in MacuCLEAR Preferred Stock. As a result of our reduced ownership, the amount of $9,304 was a transfer out of the Level 3 valuation previously recorded and was treated as a net loss for this annual period. The following is the reconciliation used in determining the value of the investment for the six months ended June 30, 2010: Investment in affiliate -------------- Beginning Balance as of 12/31/09 $ 395,620 Realized gain/(loss) - Change in unrealized appreciation/(depreciation) - Net purchase/sales - Net transfers in and/or out of Level 3 ( 9,304) -------------- Ending Balance as of 6/30/10 $ 386,316 ============== 5 Note 6. PENDING SALE Effective May 4, 2010, Regent GLSC and Healthcare of Today, Inc. ("Healthcare") executed a stock purchase agreement (the "Agreement") whereby Healthcare will acquire the Company's 30,570 shares of Series A Preferred Stock of MacuCLEAR, Inc. Under the terms of the Agreement, a share of preferred stock was scheduled to receive cash and Healthcare common stock for total consideration of $385,900. Closing was scheduled for June 30, 2010 but has been delayed pending the funding of Healthcare's public stock offering. The Board of Regent GLSC is considering other alternatives including rescission of the Agreement. The holders of the Regent GLSC Technologies, Inc. Series A Preferred Stock are beneficial owners of 95,858 shares of MacuCLEAR Inc. Series A Preferred Stock. Under the pending sale to Healthcare, these investors were scheduled to receive a distribution of cash and shares of Healthcare stock with a combined value of $1,210,485. This distribution, if closed, plus the issuance of new restricted common stock equal to approximately 10% of the outstanding stock of Regent GLSC will constitute a redemption of the Regent GLSC Series A Preferred Stock. Healthcare of Today, Inc. was incorporated in California in 2008 as a holding company focused on developing and acquiring vertically-integrated companies that offer diversified services, primarily within the healthcare industry. With more than thirty (30) subsidiaries, they operate in five core sectors: Biotechnology, Healthcare Staffing, Nurse Education, Senior Healthcare Services and Senior Care Facilities. They maintain a web site at www.healthcareoftoday.com. Note 7. RELATED PARTY TRANSACTIONS Notes receivable - ---------------- Effective December 30, 2009, the Board of the Company and the Board of Regent GLSC Technologies, Inc. approved the sale of 15,000 shares of Regent GLSC Series A Preferred Stock to the Chairman, President and CEO of Registrant for $5.00 per share. The acquisition required a payment of $5,000 plus the execution of a promissory note in the amount of $70,000 which is be unsecured but with personal liability. The terms of the note are interest at 7 per cent per annum, payable monthly, with the principal due on or before the expiration of 2 years. Notes payable - ------------- Beginning in 2005, the Company borrowed various amounts for general corporate purposes under a note payable to NR Partners, a partnership comprised of the President as a partner and director David Ramsour as a partner. The total NR Partners amount due and payable at June 30, 2010 was $4,350. The promissory note is a demand note and pays interest at 8.5 percent per annum. Preferred stock sale - -------------------- Effective January 7, 2010, Regent GLSC Technologies, Inc. executed a Preferred Stock purchase agreement for the purchase and sale of 5,000 shares of Series A Preferred Stock for $5.00 per share with the spouse of the CEO of the Company. 6 Note 8. SUBSEQUENT EVENTS On August 14, 2010, the Company entered into a rights agreement with Epi-Cloyd, Ltd. and Epi-Energy, Ltd. (E-C) for the exclusive rights to develop an E-C gear- box for the valve actuator and wind energy applications. Following a period of eight months for the development of a gearbox prototype, Regent has the right to enter into a licensee agreement for exclusive rights to a valve actuator and wind energy generation field of use. The Company's energy technologies division will seek to manufacture or license the right to manufacture a transmission for wind energy turbine customers who are presently hampered by transmissions subject to failure under extreme forces. The Company will provide these customers a revolutionary, more durable transmis- sion that not only offers longer-life but greatly reduces design, manufacture, installation, and maintenance costs compared to products available on the market today. Design and composition of the E-C gearbox and transmission is such that fabrication involves less complex equipment and forming processes as well as less exotic materials than are currently required for manufacturing wind energy transmissions. Elimination of these elements will result in considerably lower cost to manufacture and the ability to respond quickly to orders with consider- able savings to customers. The Company expects to sell its E-C transmissions in a range of 50 percent of the price currently charged for conventional transmis- sions. The Company believes the current market for wind turbine transmissions is $500 million per year. The Company expects to be selling or licensing to sell into this market in 2012. Epi-Cloyd, Ltd. and Epi-Energy, Ltd. are related private technology companies operating in Dallas, Texas and focused on the utilization of their numerous patents covering a revolutionary cyclic reduction invention. Their invention increases torque as a plurality of driver discs rotate about a central shaft member and engage an output member via a low-friction, roller means. The first of seven related patents was issued in March, 2007. Item 2. Management's Discussion and Analysis of Financial Condition - ------- ----------------------------------------------------------- and Results of Operations ------------------------- INTRODUCTION - STATEMENT OF FORWARD-LOOKING INFORMATION - ------------------------------------------------------- The Private Securities Litigation Reform Act of 1995 (the "Act") provides a safe harbor for forward-looking statements made by or on behalf of the Company. The Company and its representatives may from time to time make written or oral statements that are "forward-looking", including statements contained in this report and other filings with the Securities and Exchange Commission, reports to the Company's shareholders and news releases. All statements that express expectations, estimates, forecasts or projections are forward-looking statements within the meaning of the Act. In addition, other written or oral statements, which constitute forward-looking statements, may be made by or on behalf of the Company. Words such as "expects", "anticipates", "intends", "plans", "believes", "seeks", "estimates", "projects", "forecasts", "may", "should", variations of such words and similar expressions are intended to identify such forward-looking statements. Management cautions that forward-looking statements are subject to risks and uncertainties that could cause our actual results to differ materially from projections in such forward-looking statements. The risks, uncertainties and other important factors that may cause our results to differ materially from those projected in such forward-looking statements are detailed under the "Risk Factors" and elsewhere in our Annual Report on Form 10-K for our fiscal year ended December 31, 2009. We undertake no obligation to update a forward-looking statement to reflect subsequent events, changed circumstances, or the occurrence of unanticipated events. This discussion should be read in conjunction with the consolidated financial statements and notes presented in this Form 10-Q and the financial statements and notes in our last filed Annual Report on Form 10-K filed for the period ending December 31, 2009 for a full understanding of our financial position and results of operations for the six month period ended June 30, 2010. 7 OVERVIEW - -------- Regent Technologies, Inc., a Colorado corporation, is listed on the pink sheets under the trading symbol "REGT". The Registrant ("Regent," "Company," "we," "our" or "us") is a development stage company focused on the identification of new technologies which we believe have the potential for commercialization. We conduct operations through our subsidiary, Regent GLSC Technologies, Inc. The Company expects to form one or more additional subsidiary companies for future operations. Our strategy is to initially acquire rights to technologies and products that are at or near commercialization. During the second quarter, management had discussions regarding opportunities in oil and gas exploration and production, and proprietary technologies related thereto. We do not intend to be an investment company, engaged primarily in holding or trading in securities. Regent has funded operations through short-term borrowings and equity investment sales in order to meet obligations. Our future operations are dependent upon external funding and our ability to increase revenues and reduce expenses. There is no assurance that sufficient funding will be available from additional related party borrowings and private placements to meet our business objectives including anticipated cash needs for working capital. CRITICAL ACCOUNTING POLICIES AND ESTIMATES - ------------------------------------------ Management's discussion and analysis of financial condition and results of operations is based on the accounting policies used and disclosed in this quarterly report and in the 2009 consolidated financial statements and accompanying notes that were prepared in accordance with accounting principles generally accepted in the United States of America and included as part of the Company's annual report on Form 10-K for the year ended December 31, 2009. The preparation of the referenced consolidated financial statements required management to make estimates and assumptions that affected the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of expenses during the reporting periods. Actual amounts or results could differ from those estimates. The significant accounting policies of the Company are described in Note 1 to the 2009 Form 10-K consolidated financial statements and the critical accounting policies and estimates are described in Management's Discussion and Analysis in Item 7 of the 2009 Form 10-K. There have been no changes in the critical accounting policies. Information concerning the implementation and the impact of new accounting standards issued by the Financial Accounting Standards Board ("FASB") is included in the notes to the 2009 consolidated financial statements. RESULTS OF OPERATIONS - --------------------- Revenues The Company had no sales for the quarterly periods ended June 30, 2010 and June 30, 2009. Operating Expenses Operating expenses primarily include accounting and administrative expenses. General and administrative expenses were $14,473 for the six months ended June 30, 2010 compared to $8,818 for the six months ended June 30, 2009. The increase in administrative expenses is the result of more expenditures for stock transfer fees, audit fees, and depreciation. Interest expense was $328 for the six months ended June 30, 2010 compared to $620 during the six months ended June 30, 2009, due to the lower amount outstanding under the NR Partners promissory note. Depreciation expense for the period was $89. 8 LIQUIDITY AND CAPITAL RESOURCES - ------------------------------- As a development stage company, Regent has funded operations through short-term borrowings and equity investment sales in order to meet obligations. Our future 0perations are dependent upon external funding and our ability to increase revenues and reduce expenses. Management believes that sufficient funding will be available from additional related party borrowings and private placements to meet our business objectives including anticipated cash needs for working capital, for a reasonable period of time. As of June 30, 2010, the Company had total assets of $466,885 and total liabilities of $5,585. The Company has borrowings under a note payable to NR Partners, a partnership of which the President and one Director are the partners. The NR Partners note bears interest at a rate of 8.5 percent per annum (see Note 7). The funds have been used for general corporate purposes and the outstanding balance as of August 1, 2010 is $4,350. As of the date of this quarterly report, there is substantial doubt regarding our ability to continue as a going concern as we have not generated sufficient cash flow to fund our business operations and material commitments. Our future success and viability, therefore, are dependent upon our ability to generate capital financing. We are optimistic that we will be successful in our current business operations and capital raising efforts; however, there can be no assurance that we will be successful in generating revenue or raising additional capital. The failure to generate sufficient revenues or raise additional capital may have a material and adverse effect upon the Company and our shareholders. The Company is not performing any product research and development at this time and it is not expected to purchase equipment or incur significant changes in the number of employees. Off-Balance Sheet Arrangements As of the date of this report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. The term "off-balance sheet arrangement" generally means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with us is a party, under which we have: (i) any obligation arising under a guarantee contract, derivative instrument or variable interest; or (ii) a retained or contingent interest in assets transferred to such entity or similar arrangement that serves as credit, liquidity or market risk support for such assets. 9 Item 3. Quantitative and Qualitative Disclosures About Market Risk - ------- ---------------------------------------------------------- There have been no material changes in market risk from the information provided in our Annual Report on Form 10-K as of December 31, 2009. Item 4. Controls and Procedures - ------- ----------------------- Evaluation of Disclosure Controls and Procedures The Company's principal executive and financial officers have conducted an evaluation of the effectiveness of the Company's disclosure controls and procedures pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 as of the end of the period (the "Evaluation Date"). Based upon that evaluation, the Company's principal executive and financial officers have concluded that, as of the Evaluation Date, the Company's disclosure controls and procedures were effective in ensuring that all material information relating to the Company required to be filed in this quarterly report has been made known to them in a timely manner. The Company believes that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all issues of control and instances of fraud, if any, within any company have been detected. Changes in Internal Control over Financial Reporting No change in the Company's system of internal control over financial reporting occurred during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, internal control over financial reporting. PART II. OTHER INFORMATION Item 1. Legal Proceedings. - ------- ------------------ The Company is not aware of any pending claims or assessments, that may have a material adverse impact on Regent's financial position or operations. See Note 12 in our Annual Report on Form 10-K as of December 31, 2009 for a discussion of prior legal proceedings. Item 1A. Risk Factors. - -------- ------------- The discussion in Part I, "Item 1A. Risk Factors." in the Company's 2009 Form 10-K, of the risk factors which could materially affect the Company's business, or future results, should be carefully considered. The risks described in the Form 10-K are not the only risks facing the Company. Additional risks and uncertainties not currently known to the Company or that currently are deemed to be immaterial also may materially adversely affect the Company's business, financial condition or operating results. 10 Item 2. Changes in Securities. - ------ ---------------------- None. Item 3. Defaults Upon Senior Securities. - ------- -------------------------------- None. Item 4. Submission of Matters to a Vote of Security Holders. - ------- ---------------------------------------------------- None. Item 5. Other Information. - ------- ------------------ None. Item 6. Exhibits and Reports on Form 8-K. - ------- --------------------------------- (a) Exhibits Exhibit 31.1 Certification of C.E.O. and Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Exhibit 32.1 Certification of C.E.O. and Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (b) Reports on Form 8-K The Registrant reported the subsequent event described in Note 6 on May 12, 2010. 11 SIGNATURE In accordance with the requirements of the Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: August 16, 2010 REGENT TECHNOLOGIES, INC. (Registrant) By: /s/ David A. Nelson --------------------------------------- David A. Nelson, Chief Executive Officer (Principal Financial and Accounting Officer) 12 EXHIBIT INDEX ------------- Exhibit No. Description - ----------- ----------- 31 Certification required by Rule 13a-14(a) under the Securities Exchange Act of 1934 - Filed herewith. 32 Certification required pursuant to 18 U.S.C. Section 1350 - Filed herewith. 13